Tag: Gene mutations

news-09082024-080227

Advancing GIST Drug: IDRx Secures $120 Million Funding

IDRx, a precision oncology company based in the US, recently announced the successful completion of a $120 million series B preferred stock financing round. This funding was oversubscribed and led by RA Capital Management,...